Biomatrix Pharma

The business concept at the core of Biomatrix Pharma Limited was formulated by Gregor Lundfall and Gunnar Bronstad, combining their complementary knowledge and experience in the development and commercial exploitation of health supplements and functional foods. Biomatrix Pharma has secured the global distribution rights to the veterinary products, which will be sold under license by Biomatrix.  The research work being undertaken on health care supplements also provides the opportunity to develop these natural remedies for the human market.

The health care supplements have been developed to specifically assist with conditions or symptoms caused by an inability in some people to digest certain elements of food properly.  As well as the product’s benefits in general digestive conditions, research has revealed a specialist application in the natural treatment of side effects associated with conditions such as autism and Attention Deficit Hyperactivity Disorder (“ADHD”).